AIMS: To prospectively assess the WHO clinical decision rule (CDR) for group A beta haemolytic streptococcal (GABHS) pharyngitis in three countries. METHODS: A prospective, observational cohort study in urban outpatient clinics in Rio de Janeiro, Cairo, and Zagreb. There were 2225 children aged 2-12 years with cough, rhinorrhoea, red or sore throat; 1810 of these with sore throat were included in the analysis. RESULTS: The proportion of children presenting with sore throat and found to have GABHS pharyngitis ranged from 24.6% (Brazil) to 42.0% (Croatia). WHO CDR sensitivity was low for all sites in both age groups. In children age 5 or older, sensitivity ranged from 3.8% in Egypt to 10.8% in Brazil. In children under 5, sensitivity was low (0.0-4.6%) Specificity was high in both age groups in all countries (93.8-97.4%). CONCLUSIONS: In these populations, the current WHO CDR has high specificity, but low sensitivity; it did not detect up to 96.0% of children who have laboratory confirmed GABHS pharyngitis. A CDR with higher sensitivity should be developed for use in regions where rheumatic fever and rheumatic heart disease are still major health problems.
AIMS: To prospectively assess the WHO clinical decision rule (CDR) for group A beta haemolytic streptococcal (GABHS) pharyngitis in three countries. METHODS: A prospective, observational cohort study in urban outpatient clinics in Rio de Janeiro, Cairo, and Zagreb. There were 2225 children aged 2-12 years with cough, rhinorrhoea, red or sore throat; 1810 of these with sore throat were included in the analysis. RESULTS: The proportion of children presenting with sore throat and found to have GABHSpharyngitis ranged from 24.6% (Brazil) to 42.0% (Croatia). WHO CDR sensitivity was low for all sites in both age groups. In children age 5 or older, sensitivity ranged from 3.8% in Egypt to 10.8% in Brazil. In children under 5, sensitivity was low (0.0-4.6%) Specificity was high in both age groups in all countries (93.8-97.4%). CONCLUSIONS: In these populations, the current WHO CDR has high specificity, but low sensitivity; it did not detect up to 96.0% of children who have laboratory confirmed GABHSpharyngitis. A CDR with higher sensitivity should be developed for use in regions where rheumatic fever and rheumatic heart disease are still major health problems.
Authors: M C Steinhoff; M K Abd el Khalek; N Khallaf; H S Hamza; A el Ayadi; A Orabi; H Fouad; M Kamel Journal: Lancet Date: 1997-09-27 Impact factor: 79.321
Authors: Anne W Rimoin; Nicole A Hoff; Christa L Fischer Walker; Hala S Hamza; Adriana Vince; Naglaa Abdel Rahman; Sasa Andrasevic; Soha Emam; Dubravka Vukelic; Nevine Elminawi; Hadeer Abdel Ghafar; Antonia L A da Cunha; Shamim Qazi; Dace Gardovska; Mark C Steinhoff Journal: Clin Pediatr (Phila) Date: 2011-02-11 Impact factor: 1.168
Authors: Judith M Katzenellenbogen; Anna P Ralph; Rosemary Wyber; Jonathan R Carapetis Journal: BMC Health Serv Res Date: 2017-11-29 Impact factor: 2.655
Authors: Shereen Mohamed Abd El-Ghany; Abeer Ahmed Abdelmaksoud; Sally Mohamed Saber; Dalia Hosni Abd El Hamid Journal: Ann Saudi Med Date: 2015 Sep-Oct Impact factor: 1.526